FDA UNTITLED_LETTER - Rx Unlimited Pharmacy - October 21, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This UNTITLED LETTER record concerns Rx Unlimited Pharmacy, with an inspection on October 21, 2022, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.

Company: Rx Unlimited Pharmacy
Inspection Date: October 21, 2022
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations I
People: Nayan J. Patel (Senior Lead Reviewer and Intercenter Consult Team Leader)
Steven E. Porter (Program Division Director)
Payam Zarrabizadeh

Open in Dashboard

ID · 24b3c562-b152-4a84-b0eb-e9b438dfd22d

Violation Codes9

FD&C Act 501(a)(2)(B)21 U.S.C. 331(a)21 U.S.C. 331(k)21 U.S.C. 352(f)(1)21 U.S.C. 351(a)(2)(B)FD&C Act 505FD&C Act 501(a)(2)(A)FD&C Act 502(f)(1)21 U.S.C. 355(a)

Full citation text and observation details available on the Dashboard.